Advertisement
Research Article

APOMAB®, a La-Specific Monoclonal Antibody, Detects the Apoptotic Tumor Response to Life-Prolonging and DNA-Damaging Chemotherapy

  • Fares Al-Ejeh,

    Affiliation: Experimental Therapeutics Laboratory, Hanson Institute, Adelaide, South Australia, Australia

    X
  • Jocelyn M. Darby,

    Affiliation: Experimental Therapeutics Laboratory, Hanson Institute, Adelaide, South Australia, Australia

    X
  • Chris Tsopelas,

    Affiliation: Department of Nuclear Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia

    X
  • Douglas Smyth,

    Affiliation: Department of Nuclear Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia

    X
  • Jim Manavis,

    Affiliation: Centre for Neurological Disease, Hanson Institute, Adelaide, South Australia, Australia

    X
  • Michael P. Brown mail

    michael.brown@health.sa.gov.au

    Affiliations: Experimental Therapeutics Laboratory, Hanson Institute, Adelaide, South Australia, Australia, Department of Medical Oncology, Royal Adelaide Hospital Cancer Centre and School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia

    X
  • Published: February 27, 2009
  • DOI: 10.1371/journal.pone.0004558

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.